Boston Scientific Announces February and March 2021 Conference Schedule

 

 

MARLBOROUGH, Mass., Feb. 12, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.

On February 25, 2021, Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at the virtual SVB Leerink 10th Annual Global Healthcare Conference. The session will begin at approximately 10:40 a.m. EST.

On March 1, 2021, Meghan Scanlon, senior vice president and president, Urology and Pelvic Health, and Susie Lisa will participate in a 30-minute question-and-answer session with the host analyst at the virtual Cowen 41st Annual Health Care Conference. The session will begin at approximately 2 p.m. EST.

A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investors.  The replay will be available beginning approximately one hour following the completion of each event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS

 

Media:         

Investors:

Katie Schur                      

Susie Lisa, CFA

508-683-5574 (office)    

508-683-5565 (office)

Media Relations           

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation

Katie.Schur@bsci.com      

BSXInvestorRelations@bsci.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/boston-scientific-announces-february-and-march-2021-conference-schedule-301227326.html

SOURCE Boston Scientific Corporation

 
 
Company Codes: NYSE:BSX
 

Back to news